NorthLinks Bio is a clinical-stage biotechnology company developing broad-spectrum prophylactic for respiratory viruses.  The company’s lead candidate, HEX17, is a first-in-class intranasal spray designed to prevent infection by targeting host-cell receptors involved in viral entry and has already demonstrated protection against influenza in a Phase 2 human challenge study.  Built on the company’s proprietary glycan-targeted platform, NorthLinks Bio is advancing a strain-agnostic approach intended to provide protection against multiple respiratory viruses while maintaining activity despite viral evolution.  NorthLinks Bio is headquartered in Boston, Massachusetts, with research operations in St. Andrews, Scotland.

NorthLinks Bio

Org chart

Teams

Offices

NorthLinks Bio

Org chart

Teams

Offices

Related companies